
Earnings season blog: Alphabet, Uber, and more

Re-live our live blog coverage of earnings season! This is the time of year when publicly traded companies report their financial results, giving investors and analysts a glimpse into their performance and future outlook. We'll bring you real-time updates, analysis, and commentary on the latest earnings reports from major companies across various sectors. Stay tuned as we break down the numbers and provide insights into what these results mean for the market. ______________________________________________________________________________________Summary Eli Lilly soars on weight loss drug revenueQualcomm issues weak guidance amid memory shortageAlphabet forecasts massive capital expendituresUber beats revenue estimates despite income hitNovo Nordisk shares plummet as it projects drop in salesThe New York Times Company's profits and expenses both riseSony lifts its guidance_______________________________________________________________________________________ 8:53 am (AEDT): Good morning! Harlan Ockey here to walk you through the day's earnings. Starting off on the NYSE, Eli Lilly (LLY) surged past estimates as revenue for its weight loss medications continued to rise. Total revenue was up 43% year-over-year to US







